Literature DB >> 2726754

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

R Orlandi1, D H Güssow, P T Jones, G Winter.   

Abstract

We have designed a set of oligonucleotide primers to amplify the cDNA of mouse immunoglobulin heavy and light chain variable domains by the polymerase chain reaction. The primers incorporate restriction sites that allow the cDNA of the variable domains to be force-cloned for sequencing and expression. Here we have applied the technique to clone and sequence the variable domains of five hybridoma antibodies and to express a mouse-human chimeric antibody that binds to the human mammary carcinoma line MCF-7. The technique should also lead to the cloning of antigen-binding specificities directly from immunoglobulin genes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726754      PMCID: PMC287235          DOI: 10.1073/pnas.86.10.3833

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Mutagenesis in vitro by DNA polymerase from an RNA tumour virus.

Authors:  K P Gopinathan; L A Weymouth; T A Kunkel; L A Loeb
Journal:  Nature       Date:  1979-04-26       Impact factor: 49.962

Review 4.  The dynamic nature of the antibody repertoire.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1988-10       Impact factor: 12.988

5.  Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.

Authors:  A L Bothwell; M Paskind; M Reth; T Imanishi-Kari; K Rajewsky; D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

6.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA.

Authors:  M A Innis; K B Myambo; D H Gelfand; M A Brow
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  135 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.

Authors:  J Lescar; J Brynda; P Rezacova; R Stouracova; M M Riottot; V Chitarra; M Fabry; M Horejsi; J Sedlacek; G A Bentley
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

3.  N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.

Authors:  P Saviranta PJauria; U Lamminmäki; J Hellman; S Eriksson; T Lövgren
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

4.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Reconstruction and expression of chimeric anti-HBx antibody in Escherichia coli.

Authors:  G Zhou; K D Liu; Z Y Tang; Y H Chen; X F Wu; C H Schroeder
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Expression of a Chlamydia anticarbohydrate single-chain antibody as a maltose binding fusion protein.

Authors:  D P Malinowski; M Gourley; S Edelstein; R E Pearson
Journal:  Cell Biophys       Date:  1992 Aug-Dec

Review 7.  The polymerase chain reaction and other amplification techniques in immunological research and diagnosis.

Authors:  A M Lew; R B Brandon; M Panaccio; C J Morrow
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Probing myosin light chain 1 structure with monoclonal antibodies.

Authors:  B Cornillon; A M Cathiard; P Eldin; M Anoal; R Cardinaud; J P Liautard; M Le Cunff; D Mornet; F Pons; J Leger
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

9.  In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells.

Authors:  M J Embleton; G Gorochov; P T Jones; G Winter
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

10.  A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.

Authors:  M Levi; M Sällberg; U Rudén; D Herlyn; H Maruyama; H Wigzell; J Marks; B Wahren
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.